Wasan, H., Meade, A. M., Adams, R., Wilson, R., Pugh, C., Fisher, D., . . . Maughan, T. (2014). Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): A randomised phase 2 trial. Lancet Pub. Group.
Chicago ZitierstilWasan, Harpreet, et al. Intermittent Chemotherapy Plus Either Intermittent or Continuous Cetuximab for First-line Treatment of Patients With KRAS Wild-type Advanced Colorectal Cancer (COIN-B): A Randomised Phase 2 Trial. Lancet Pub. Group, 2014.
MLA ZitierstilWasan, Harpreet, et al. Intermittent Chemotherapy Plus Either Intermittent or Continuous Cetuximab for First-line Treatment of Patients With KRAS Wild-type Advanced Colorectal Cancer (COIN-B): A Randomised Phase 2 Trial. Lancet Pub. Group, 2014.